Talk:Bremelanotide
| This is the talk page for discussing improvements to the Bremelanotide article. This is not a forum for general discussion of the subject of the article. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
| Archives: 1 |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Bremelanotide.
|
Wiki Education Foundation-supported course assignment
edit
This article was the subject of a Wiki Education Foundation-supported course assignment, between 3 September 2019 and 12 December 2019. Further details are available on the course page. Student editor(s): Sdavid5304.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 16:14, 16 January 2022 (UTC)
Should Palatin Technologies have it's own article? It just redirects here now for some reason, I guess this their closest product to market. Endercase (talk) 18:14, 6 April 2017 (UTC)
- I kind of doubt whether they are really notable enough to have their own article. but if somebody wants to try, they can find out. Jytdog (talk) 20:10, 6 April 2017 (UTC)
Placebo. Daily sex?
edithttps://www.livescience.com/65784-how-womens-libido-drug-works.html
- 25% of those who took bremelanotide saw some improvements in their reported sexual desire scores, compared with 17% who took a placebo.
(25-17=8%, so could this medicine be replaced by placebo?)
- Women should not take more than one dose of bremelanotide within a 24-hour period or more than 8 doses per MONTH.
(What if the partner wishes to have sex daily, not 8 times a month?)
"Palatin Technologies" listed at Redirects for discussion
edit
The redirect Palatin Technologies has been listed at redirects for discussion to determine whether its use and function meets the redirect guidelines. Readers of this page are welcome to comment on this redirect at Wikipedia:Redirects for discussion/Log/2023 December 4 § Palatin Technologies until a consensus is reached. (t · c) buidhe 06:10, 4 December 2023 (UTC)
Proposed addition to Other sources / External links
edit | The user below has a request that an edit be made to Bremelanotide. That user has an actual or apparent conflict of interest. The requested edits backlog is very high. Please be extremely patient. There are currently 534 requests waiting for review. Please read the instructions for the parameters used by this template for accepting and declining them, and review the request below and make the edit if it is well sourced, neutral, and follows other Wikipedia guidelines and policies. |
Could an uninvolved editor please review whether the following link would be appropriate for an “Other sources” or “External links” section in this article, if such a section is considered suitable under WP:EL and WP:ELNO?
Proposed link:
- Peptides.io PT-141 guide – plain-language overview of PT-141/bremelanotide, including general background, mechanism, FDA-approved use context, off-label-use disclaimer, and safety notes
I am asking here rather than adding it directly because bremelanotide is a medical/pharmacology topic, and I want to avoid adding anything that editors may consider promotional, non-neutral, or unsuitable as an external link. If editors feel this link is not appropriate for the article, I am fine with leaving it out.
For transparency, I am connected to Peptides.io, so I am requesting review by uninvolved editors rather than making the article edit myself, in line with WP:COI.
Andrei25luks (talk) 08:15, 13 July 2026 (UTC)
- Not appropriate. That is a commercial website. Constant314 (talk) 20:02, 13 July 2026 (UTC)